SCHEMBL6301170

SCHEMBL6301170

CCOC(=O)c1ccc2nc(C)n(Cc3ccc(O)cc3Cl)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.52
PDE2A O00408 2/20 0.46
PDE10A Q9Y233 1/20 0.46
ALDH1A1 P00352 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
KDM4E B2RXH2 2/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
RAB9A P51151 1/20 0.41
MAPT P10636 2/20 0.41
ATM Q13315 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173254 0.91 PPARG (0.62) PPARGPDE2APDE10AALDH1A1L3MBTL1
SCHEMBL6308856 0.90 PPARG (0.52) PPARGPDE2APDE10AALDH1A1L3MBTL1
SCHEMBL7654594 0.90 PPARG (0.52) PPARGPDE2APDE10AALDH1A1L3MBTL1
SCHEMBL7652168 0.90 PPARG (0.54) PPARGPDE2APDE10AALDH1A1L3MBTL1
SCHEMBL6304484 0.89 PPARG (0.51) PPARGPDE2APDE10AALDH1A1L3MBTL1
SCHEMBL6303281 0.89 PPARG (0.51) PPARGPDE2APDE10AALDH1A1L3MBTL1
SCHEMBL6307898 0.89 PPARG (0.51) PPARGPDE2APDE10AALDH1A1L3MBTL1
SCHEMBL7657817 0.88 PPARG (0.51) PPARGPDE2APDE10AALDH1A1L3MBTL1
SCHEMBL6303866 0.88 PPARG (0.51) PPARGPDE2APDE10AALDH1A1L3MBTL1
SCHEMBL6169005 0.87 PDE2A (0.55) PPARGPDE2APDE10AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6869950-B1 Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-03-22 US disclosed
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US disclosed
EP-1142880-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-10 EP disclosed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed